| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0074 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |